Authors

Qing Meng, PhD, MD, DABCC, FAACC

Director of Clinical Chemistry; Professor of Laboratory Medicine
University of Texas MD Anderson Cancer Center
Interests: Clinical chemistry, immunoassay, tumor markers, TDM
Qing He Meng, PhD, MD, DABCC, FAACC, is professor and section chief of clinical chemistry laboratories, department of laboratory medicine, at The University of Texas MD Anderson Cancer Center. He earned his MD in 1985 from Xuzhou Medical College, Jiangsu, China and his PhD in Clinical Chemistry from the University of Helsinki, Finland in 1999. Qing has served as the President of the Canadian Academy of Clinical Biochemistry and as the Chair of Division Management and Membership Taskforce for AACC, in addition to numerous other committee appointments over the years. He currently sits for the Committee on Analytical Quality for IFCC and the AACC Science and Practice Core Committee, and is Chair of the AACC Texas section and Chair of AACC’s Tumor Markers and Cancer Diagnostics Division.

Current Issue